Renal Cell Cancer Update

Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation

Informações:

Sinopse

Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates on available and emerging treatment strategies for non-small cell lung cancer with an EGFR mutation. CME information and select publications here (https://www.researchtopractice.com/EGFRNSCLCThinkTank2024)